240
Participants
Start Date
July 14, 2020
Primary Completion Date
June 1, 2027
Study Completion Date
June 1, 2027
TTX-080
Variable dose (Q3W)
TTX-080
Specified dose (Q3W)
pembrolizumab
Specified dose (Q3W)
cetuximab
Specified dose on specified days
FOLFIRI
Specified dose (Q2W)
cetuximab
Specified dose (Q2W)
TTX-080
Specified dose (Q2W)
COMPLETED
Icahn School of Medicine at Mount Sinai, New York
COMPLETED
Stony Brook University, Stony Brook
COMPLETED
University of Pittsburgh Medical Center, Pittsburgh
COMPLETED
Christiana Care Helen F. Graham Cancer Center, Newark
COMPLETED
John Hopkins Kimmer Cancer Center, Washington D.C.
RECRUITING
Maryland Oncology Hematology, Silver Spring
RECRUITING
NEXT Oncology Virginia, Fairfax
COMPLETED
Medical University of South Carolina, Charleston
COMPLETED
Florida Cancer Specialists, Fleming Island
RECRUITING
Florida Cancer Specialists, Daytona Beach
COMPLETED
AdventHealth Research Institute, Orlando
RECRUITING
Ocala Oncology Center, Ocala
RECRUITING
Sarah Cannon Research Institute, Nashville
COMPLETED
Vanderbilt - Ingram Cancer Center, Nashville
COMPLETED
Norton Cancer Institute, Louisville
COMPLETED
Zangmeister Cancer Center, Columbus
COMPLETED
The University of Toledo, Toledo
RECRUITING
University of Cincinnati, Cincinnati
COMPLETED
Indiana University, Indianapolis
COMPLETED
START Midwest, Grand Rapids
RECRUITING
Regions Hospital Cancer Care Center, Saint Paul
COMPLETED
Illinois Cancer Specialists, Arlington Heights
COMPLETED
University of Illinois, Chicago
COMPLETED
Washington University in St Louis, St Louis
RECRUITING
Nebraska Cancer Center Oncology Hematology West P.C., Omaha
RECRUITING
University of Oklahoma, Oklahoma City
RECRUITING
Texas Oncology - Dallas, Dallas
RECRUITING
Texas Oncology - Paris, Paris
COMPLETED
The University of Texas MD Anderson Cancer Center, Houston
COMPLETED
NEXT Oncology, San Antonio
RECRUITING
Rocky Mountain Cancer Centers, Denver
COMPLETED
Arizona Oncology Associates, Tucson
COMPLETED
University of Southern California, Los Angeles
COMPLETED
Hoag Memorial Hospital, Newport Beach
COMPLETED
Northwest Medical Specialties, Tacoma
COMPLETED
Northwest Cancer Specialists, Vancouver
COMPLETED
Yale Cancer Center, New Haven
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Rutgers Cancer Institute of New Jersey, New Brunswick
Tizona Therapeutics, Inc
INDUSTRY